Literature DB >> 20125064

Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.

Ki-Soo Park1, Young-Seok Kim, Jae-Hyeon Kim, Bongkum Choi, Sa-Hyun Kim, Alice Hyun-Kyung Tan, Myung-Shik Lee, Moon-Kyu Lee, Choon-Hyuck Kwon, Jae-Won Joh, Sung-Joo Kim, Kwang-Won Kim.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs), also known as multipotent progenitor cells, release several factors that support cell survival and enhance wound healing. We hypothesized that MSC-secreted molecules would induce a trophic effect in pancreatic islet culture conditions.
METHODS: Pancreatic islets were co-cultured with MSCs, and ADP/ATP ratios, glucose stimulated insulin secretion (GSIS), and DNA fragmentation were evaluated to measure islet quality and viability in vitro. The induction of signal molecules related to the control of survival, function, and angiogenesis was also analyzed. Cell quality assays, DNA fragmentation assays, and islet transplantation into streptozotocin-induced diabetic mice were performed using MSC-conditioned medium (CM)-cultured islets. Furthermore, we identified soluble molecules within MSC-CM.
RESULTS: Islets co-cultured with MSCs demonstrated lower ADP/ATP ratios, and higher GSIS indexes and viability. Furthermore, co-cultured islets revealed higher levels of anti-apoptotic signal molecules (X-linked inhibitor of apoptosis protein, Bcl-xL, Bcl-2, and heat shock protein-32) and demonstrated increased vascular endothelial growth factor receptor 2 and Tie-2 mRNA expression and increased levels of phosphorylated Tie-2 and focal adhesion kinase protein. Islets cultured in MSC-CM demonstrated lower ADP/ATP ratios, less apoptosis, and a higher GSIS indexes. Diabetic mice that received islet transplants (200 islet equivalent) cultured in MSC-CM for 48 hr demonstrated significantly lower blood glucose levels and enhanced blood vessel formation. In addition, interleukin-6, interleukin-8, vascular endothelial growth factor-A, hepatocyte growth factor, and transforming growth factor-beta were detected at significant levels in MSC-CM.
CONCLUSIONS: These results suggest that the trophic factors secreted by human MSCs enhance islet survival and function after transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125064     DOI: 10.1097/TP.0b013e3181c7dc99

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  77 in total

Review 1.  Mesenchymal stromal cells (MSCs): science and f(r)iction.

Authors:  Karen Bieback; Patrick Wuchter; Daniel Besser; Werner Franke; Matthias Becker; Michael Ott; Martin Pacher; Nan Ma; Christof Stamm; Harald Klüter; Albrecht Müller; Anthony D Ho
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

2.  Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.

Authors:  Arsalan Shabbir; David Zisa; Huey Lin; Michalis Mastri; Gregory Roloff; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

Review 3.  The stem cell niche should be a key issue for cell therapy in regenerative medicine.

Authors:  José Becerra; Leonor Santos-Ruiz; José A Andrades; Manuel Marí-Beffa
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 4.  Mesenchymal stem cells as feeder cells for pancreatic islet transplants.

Authors:  Valeria Sordi; Lorenzo Piemonti
Journal:  Rev Diabet Stud       Date:  2010-08-10

5.  Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.

Authors:  Chloe L Rackham; Paramjeet K Dhadda; Aurélie M Le Lay; Aileen J F King; Peter M Jones
Journal:  Cell Med       Date:  2014-03-24

6.  Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo.

Authors:  Simen W Schive; Mohammad Reza Mirlashari; Grete Hasvold; Mengyu Wang; Dag Josefsen; Hans Petter Gullestad; Olle Korsgren; Aksel Foss; Gunnar Kvalheim; Hanne Scholz
Journal:  Cell Med       Date:  2017-04-14

Review 7.  Bioengineered sites for islet cell transplantation.

Authors:  Sophie Vériter; Pierre Gianello; Denis Dufrane
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 8.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

9.  Integration of mesenchymal stem cells into islet cell spheroids improves long-term viability, but not islet function.

Authors:  Sonia Rawal; S Janette Williams; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Islets       Date:  2017-06-29       Impact factor: 2.694

Review 10.  The potential of cell-based therapy for diabetes and diabetes-related vascular complications.

Authors:  Aaron Liew; Timothy O'Brien
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.